Jiang Rensheng & family
$4.64B
as of 08/18/26
About Jiang Rensheng & family
Jiang Rensheng is the chairman of Shenzhen-listed vaccine firm Chongqing Zhifei Biological Products.
A longtime distribution partner of Merck, Zhifei won the Chinese sales rights to the U.S. pharma's HPV drug in 2018.
In 2023, Jiang took his antibody drug maker Chongqing Genrix Biopharmaceutical public on the Shanghai Stock Exchange.
Prior to striking out on his own, he worked as a primary school teacher and a government health official.
In 2024, Zhifei entered an exclusive partnership with GSK, a pharma headquartered in the UK, to distribute shingles vaccines and explore RSV vaccine commercialization in China.
Personal stats
Citizenship
People's Republic of ChinaSource of wealth
VaccinesResidence
Chongqing, People's Republic of ChinaMarital status
MarriedBirth date
10/08/53 (age 72)Number of children
1Education
Associate in Arts/Science, Guilin Medical UniversitySelf-made
self-madeJiang Rensheng & family’s fortune is worth
77K
troy ounces of gold
71K
median U.S. household
46K
median U.S. income
0.093%
U.S. credit card volume
0.019%
GDP of the United States
0.014%
United States debt
Net worth history
Annual ranking
Related people
Net worth over time
Real-time ranking
Financial assets
SHANGHAI | 688443-CN
Chongqing Genrix BiopharmaceuticalSHENZHEN | 300122-CN
Chongqing Zhifei Biological Products Co LtdSHENZHEN | 300122-CN
Chongqing Zhifei Biological Products Co LtdImages © Forbes.com. All rights reserved.